The Physiological mTOR Complex 1 Inhibitor DDIT4 Mediates Therapy Resistance in Glioblastoma

British Journal of Cancer - United Kingdom
doi 10.1038/s41416-018-0368-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Augmented HR Repair Mediates Acquired Temozolomide Resistance in Glioblastoma

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2016English

Mighty RapaLink-1 Vanquishes Undruggable Mutant mTOR in Glioblastoma

Translational Cancer Research
Cancer ResearchOncologyRadiologyNuclear MedicineImaging
2017English

Targeting Resistance Against the MDM2 Inhibitor RG7388 in Glioblastoma Cells by the MEK Inhibitor Trametinib

Clinical Cancer Research
Cancer ResearchOncology
2018English

mTOR Signaling Mediates Resistance to Tankyrase Inhibitors in WNT-Driven Colorectal Cancer

Oncotarget
Oncology
2017English

Structural Insights of mTOR Complex 1

Cell Research
Cell BiologyMolecular Biology
2016English

APOBEC3 Mediates Resistance to Oncolytic Viral Therapy

Molecular Therapy - Oncolytics
Cancer ResearchOncologyMolecular MedicinePharmacology
2018English

mTOR Complex 2 Mediates Akt Phosphorylation That Requires PKCε in Adult Cardiac Muscle Cells

Cellular Signalling
Cell Biology
2013English

EGFR and mTOR as Therapeutic Targets in Glioblastoma

Oncotarget
Oncology
2019English

mTOR Complex 2 Controls Glycolytic Metabolism in Glioblastoma Through FoxO Acetylation and Upregulation of C-Myc

Cell Metabolism
Cell BiologyMolecular BiologyPhysiology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy